Cardiac Troponin T After Transcatheter Closure of the Interatrial Septum
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03099967|
Recruitment Status : Completed
First Posted : April 4, 2017
Last Update Posted : April 4, 2017
Skane University Hospital
Information provided by (Responsible Party):
Joanna Hlebowicz, Skane University Hospital
To examine retrospectively whether transcatheter closure of the interatrial septum leads to myocardial injury and to determine the mechanism.
|Condition or disease||Intervention/treatment|
|Congenital Heart Disease||Device: Transcatheter closure of an atrial septal defect or patent foramen ovale.|
|Study Type :||Observational|
|Actual Enrollment :||51 participants|
|Official Title:||Cardiac Troponin T After Transcatheter Closure of the Interatrial Septum|
|Study Start Date :||January 1, 2005|
|Actual Primary Completion Date :||January 1, 2017|
|Actual Study Completion Date :||January 1, 2017|
- Device: Transcatheter closure of an atrial septal defect or patent foramen ovale.
In a prospective study in adults troponin T (TnT) serum concentrations were determined before and the day after transcatheter closure of an atrial septal defect (ASD) or patent foramen ovale (PFO).
Primary Outcome Measures :
- TnT changes [ Time Frame: Blood samples for TnT were taken one day before intervention and one day after intervention. ]
No Contacts or Locations Provided